Literature DB >> 15935976

Tumor response assessment is more robust with sequential CT scanning than external caliper measurements.

Takayoshi Ishimori1, Mitsuaki Tatsumi, Richard L Wahl.   

Abstract

RATIONALE AND
OBJECTIVES: Measurements of tumor size are important in assessing response to cancer therapies. To date, preclinical studies of drug development have relied on direct caliper-based measurements of tumor size. We investigated the feasibility of using a human positron emission tomographic (PET)/computed tomographic (CT) scanner to assess tumor size before and after chemotherapy and compared this approach with caliper measurements.
MATERIALS AND METHODS: Fourteen rats with rat mammary tumor underwent high-resolution CT using a PET/CT scanner before and after chemotherapy, and tumor volumes were measured independently by two observers using calipers and CT images.
RESULTS: Tumor response could be detected after 1 day of treatment by means of CT imaging, but was not significant until 2 days or later by means of caliper measures because of their greater variability. Independent measurements of tumor size correlated well with one another by means of CT, but correlated less by means of calipers.
CONCLUSION: Tumor size measurements by means of CT from PET/CT were more reliable than caliper measurements because of their smaller variance, allowing earlier assessment of response. It is suggested that CT imaging-based methods of assessing tumor response replace traditional caliper-based measurements, much as CT has become a standard for assessing tumor response in humans.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15935976     DOI: 10.1016/j.acra.2005.03.062

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  10 in total

1.  Semi-automatic cone beam CT segmentation of in vivo pre-clinical subcutaneous tumours provides an efficient non-invasive alternative for tumour volume measurements.

Authors:  N P Brodin; J Tang; K Skalina; T J Quinn; I Basu; C Guha; W A Tomé
Journal:  Br J Radiol       Date:  2015-03-31       Impact factor: 3.039

2.  Imaging tumor growth non-invasively using expression of MagA or modified ferritin subunits to augment intracellular contrast for repetitive MRI.

Authors:  Roja Rohani; Rene Figueredo; Yves Bureau; James Koropatnick; Paula Foster; R Terry Thompson; Frank S Prato; Donna E Goldhawk
Journal:  Mol Imaging Biol       Date:  2014-02       Impact factor: 3.488

3.  Volume of preclinical xenograft tumors is more accurately assessed by ultrasound imaging than manual caliper measurements.

Authors:  Gregory D Ayers; Eliot T McKinley; Ping Zhao; Jordan M Fritz; Rebecca E Metry; Brenton C Deal; Katrina M Adlerz; Robert J Coffey; H Charles Manning
Journal:  J Ultrasound Med       Date:  2010-06       Impact factor: 2.153

4.  The current role of PET-CT in the characterization of hepatobiliary malignancies.

Authors:  Ginseppe Garcea; Seok Ling Ong; Guy J Maddern
Journal:  HPB (Oxford)       Date:  2009-02       Impact factor: 3.647

5.  Small animal absorbed radiation dose from serial micro-computed tomography imaging.

Authors:  Stephanie K Carlson; Kelly L Classic; Claire E Bender; Stephen J Russell
Journal:  Mol Imaging Biol       Date:  2007 Mar-Apr       Impact factor: 3.488

6.  In vivo quantitation of intratumoral radioisotope uptake using micro-single photon emission computed tomography/computed tomography.

Authors:  Stephanie K Carlson; Kelly L Classic; Elizabeth M Hadac; Claire E Bender; Bradley J Kemp; Val J Lowe; Tanya L Hoskin; Stephen J Russell
Journal:  Mol Imaging Biol       Date:  2006 Nov-Dec       Impact factor: 3.484

7.  An innovative non-invasive technique for subcutaneous tumour measurements.

Authors:  Juan Delgado-SanMartin; Beate Ehrhardt; Marcin Paczkowski; Sean Hackett; Andrew Smith; Wajahat Waraich; James Klatzow; Adeala Zabair; Anna Chabokdast; Leonardo Rubio-Navarro; Amar Rahi; Zena Wilson
Journal:  PLoS One       Date:  2019-10-14       Impact factor: 3.240

8.  [18F]FLT and [18F]FDG PET for non-invasive treatment monitoring of the nicotinamide phosphoribosyltransferase inhibitor APO866 in human xenografts.

Authors:  Mette Munk Jensen; Kamille Dumong Erichsen; Camilla Bardram Johnbeck; Fredrik Björkling; Jacob Madsen; Michael Bzorek; Peter Buhl Jensen; Liselotte Højgaard; Maxwell Sehested; Andreas Kjær
Journal:  PLoS One       Date:  2013-01-04       Impact factor: 3.240

9.  Tumor volume in subcutaneous mouse xenografts measured by microCT is more accurate and reproducible than determined by 18F-FDG-microPET or external caliper.

Authors:  Mette Munk Jensen; Jesper Tranekjaer Jørgensen; Tina Binderup; Andreas Kjaer
Journal:  BMC Med Imaging       Date:  2008-10-16       Impact factor: 1.930

10.  Gradient-Based Algorithm for Determining Tumor Volumes in Small Animals Using Planar Fluorescence Imaging Platform.

Authors:  Jessica P Miller; Christopher Egbulefu; Julie L Prior; Mingzhou Zhou; Samuel Achilefu
Journal:  Tomography       Date:  2016-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.